Amicus Therapeutics

Amicus Therapeutics

Amicus Therapeutics

Biotech
Founded
2002
Raised
$41M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$10,000,000
Debt financing - 2013
$31,000,000
Venture capital (Series B) - 2004
Team Size
50+
Employees
the home of AI info

Comparing of Amicus Therapeutics Inc. (FOLD) and Minerva Neurosciences Inc. (NASDAQ:NERV)

Xconomy

Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement

Health Science
Xconomy

Amicus Takes Aim at Rare Brain Disorder with MiaMed Acquisition

Health
Xconomy

Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug

Health
The Motley Fool

Why Amicus Therapeutics, Inc. Stock Slumped 14.0% in April

The Motley Fool

What Caused Amicus Therapeutics Shares To Skyrocket 23% Last Month

Health Stock markets
The Motley Fool

Amicus Therapeutics Closes In on a 9-Figure Opportunity

The Motley Fool

3 Emerging Biotech Stocks I'm Watching Like a Hawk

The Motley Fool

Why Amicus Therapeutics Shares Are Skyrocketing Again Today

Stock markets
The Motley Fool

Why Amicus Therapeutics Shares Are Up Today

Stock markets
The Motley Fool

Why Amicus Therapeutics Shares Are Soaring 10% Today --

Stock markets Health